Jun 5 |
Akari Therapeutics announces interm CEO employment contract
|
Jun 5 |
Akari Therapeutics Announces Interim CEO Employment Contract Demonstrating Alignment with Shareholders
|
Jun 4 |
Akari Therapeutics raises $7.6M in upsized financing round
|
Jun 4 |
Akari Therapeutics Secures $7.6 Million in Upsized Financing Round
|
May 16 |
Akari Therapeutics GAAP EPS of $0.00
|
May 16 |
Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
|
May 1 |
Akari gains despite leadership change amid portfolio shakeup
|
May 1 |
Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
|
May 1 |
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
|
Apr 15 |
Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024
|